Hepatic infantile hemangiomas treated with oral propranolol - A case series

Pediatric Dermatology

Volumn 28, Issue 1, 2011, Pages 39-45

  Mhanna, Amal ^a,b   Franklin, Wayne H ^a,b   Mancini, Anthony J ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DIGOXIN; FUROSEMIDE; LEVOTHYROXINE; PROPRANOLOL; RANITIDINE; SPIRONOLACTONE; THYROTROPIN;

ABDOMINAL RADIOGRAPHY; ABSENCE OF SIDE EFFECTS; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE HEART FAILURE; COUGHING; DIAPHORESIS; DRUG DOSE INCREASE; DRUG TOLERABILITY; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FACE; FEEDING DISORDER; FEMALE; HEART MURMUR; HEPATOMEGALY; HIGH OUTPUT HEART FAILURE; HOLTER MONITORING; HORMONE SUBSTITUTION; HUMAN; HYPOTHYROIDISM; INFANT; LIVER HEMANGIOMA; MALE; MULTIPLE CANCER; PATENT DUCTUS ARTERIOSUS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REMISSION; SKIN HEMANGIOMA; THYROID FUNCTION; THYROTROPIN BLOOD LEVEL; TUMOR VOLUME; ULTRASOUND;

ADRENERGIC BETA-ANTAGONISTS; FEMALE; HEART FAILURE; HEMANGIOMA; HEMANGIOMA, CAPILLARY; HUMANS; HYPOTHYROIDISM; INFANT; LIVER NEOPLASMS; PROPRANOLOL; SKIN NEOPLASMS; THYROXINE; TREATMENT OUTCOME;

EID: 79551551069     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2010.01355.x     Document Type: Article

References (32)

1. Metry DW, Hebert AA,. Benign cutaneous vascular tumors of infancy. Arch Dermatol 2000; 136: 905-914.
2. Jacobs AH,. Strawberry hemangiomas: the natural history of the untreated lesion. Calif Med 1957; 86: 8-10.
3. Boon LM, Burrows PE, Paltiel HJ, et al. Hepatic vascular anomalies in infancy: a twenty-seven-year experience. J Pediatr 1996; 129: 346-354.
4. Kassarjian A, Zurakowski D, Dubois J, et al. Infantile hepatic hemangiomas: clinical and imaging findings and their correlation with therapy. Am J Roentgenol 2004; 182: 785-795.
5. Vlahovic A, Simic R, Djokic D, et al. Diffuse neonatal hemangiomatosis treatment with cyclophosphamide: a case report. J Pediatr Hematol Oncol 2009; 31: 858-860.
6. Markiewicz-Kijewska M, Kaspryzk W, Broniszczak D, et al. Hemodynamic failure as an indication to urgent liver transplantation in infants with giant hepatic hemangiomas or vascular malformations-report of four cases. Pediatr Transplant 2009; 13: 906-912.
7. Hurvitz SA, Hurvitz CH, Sloninsky L, et al. Successful treatment with cyclophosphamide of life-threatening diffuse hemangiomatosis involving the liver. J Pediatr Hematol Oncol 2000; 22: 527-532.
8. Schiavetti A, De Pasquale MD, Di Salvo S, et al. Recombinant interferon alfa 2a in hepatic hemangiomatosis with congestive heart failure: a case report. Pediatr Hematol Oncol 2003; 20: 161-165.
9. Stratte EG, Tope WD, Johnson CL, et al. Multimodal management of diffuse neonatal hemangiomatosis. J Am Acad Dermatol 1996; 2 (Pt2): 337-342.
10. Dickie B, Dasgupta R, Nair R, et al. Spectrum of hepatic hemangiomas: management and outcome. J Pediatr Surg 2009; 44: 125-133.
11. Leaute-Labreze C, Dumas de la Roque E, Hubiche T, et al. Propranolol for severe hemangioma (letter to the editor). N Engl J Med 2008; 358: 2649-2651.
12. Lawley LP, Siegfried E, Todd Jane L,. Propranolol treatment for hemangioma of infancy: risks and recommendations. Pediatr Dermatol 2009; 26: 610-614.
13. Buckmiller LM,. Propranolol treatment for infantile hemangiomas. Curr Opin Otolaryngol Head Neck Surg 2009; 17: 458-459.
14. Buckmiller LM, Dyamenahalli U, Richter GT,. Propranolol for airway hemangiomas: case report of novel treatment. Laryngoscope 2009; 119: 2051-2054.
15. Sommers Smith SK, Smith DM,. Beta blockade induces apoptosis in cultured capillary endothelial cells. In Vitro Cell Dev Biol Anim 2002; 38: 298-304.
16. Takahata Y, Takarada T, Iemata M, et al. Functional expression of beta 2 adrenergic receptors responsible for protection against oxidative stress through promotion of glutathione synthesis after Nrf2 upregulation in undifferentiated mesenchymal C3H10T1/2 stem cells. J Cell Physiol 2009; 218: 268-275.
17. Chang LC, Haggstrom AM, Drolet AB, et al. Growth characteristics of infantile hemangiomas: implications for management. Pediatrics, 2008; 122: 360-367.
18. Christison-Lagay ER, Burrows PE, Alomari A, et al. Hepatic hemangiomas: subtype classification and development of a clinical practice algorithm and registry. J Pediatr Surg 2007; 42: 62-68.
19. Lu CC, Ko SF, Liang CD, et al. Infantile hepatic hemangionendothelioma presenting as early heart failure: report of two cases. Chang Gung Med J 2002; 25: 405-410.
20. Kalpatthi R, Germak J, Mizelle K, et al. Thyroid abnormalities in infantile hepatic hemangionenothelioma. Pediatr Blood Cancer 2007; 49: 1021-1024.
21. Cho YH, Taplin C, Mansour A, et al. Case report: consumptive hypothyroidism consequent to multiple infantile hepatic haemangiomas. Curr Opin Pediatr 2008; 20: 213-215.
22. Bessho K, Etani Y, Ichimori H, et al. Increased type 3 iodothyronine deiodinase activity in a regrown hepatic hemangioma with consumptive hypothyroidism. Eur J Pediatr 2010; 169: 215-221.
23. Paltiel HJ, Patriquin HB, Keller MS, et al. Infantile hepatic hemangioma: Doppler US. Radiology 1992; 182: 735-742.
24. Boon LM, MacDonald DM, Mulliken JB,. Complications of systemic corticosteroid therapy for problematic hemangioma. Plast Reconstr Surg 1999; 104: 1616-1623.
25. Barlow CF, Priebe CJ, Mulliken JB, et al. Spastic diplegia as a complication of interferon-alpha-2a treatment of hemangiomas of infancy. J Pediatr 1998; 132: 527-530.
26. Siau C, Xiao W, Bennett GJ,. Paclitaxel- and vincristine-evoked painful peripheral neuropathies: loss of epidermal innervations and activation of Langerhans cells. Exp Neurol 2006; 201: 507-514.
27. Pereyra R, Andrassy RJ, Mahour GH,. Management of massive hepatic hemangiomas in infants and children: a review of 13 cases. Pediatrics 1982; 70: 254-258.
28. Enjolras O, Riche MC, Merland JJ, et al. Management of alarming hemangiomas in infancy: a review of 25 cases. Pediatrics 1990; 85: 491-498.
29. Sans V, Dumas de la Roque E, Berge J, et al. Propranolol for severe infantile hemangiomas: follow-up report. Pediatrics 2009; 124: e423-e431.
30. Love JN, Sikka Neal,. Are 1-2 tablets dangerous? Beta-blockers exposure in toddlers. J Emerg Med 2004; 26: 309-314.
31. Marsciani A, Pericoli R, Alaggio R, et al. Letter to the editor: massive response of severe infantile hepatic hemangioma to propranolol. Pediatr Blood Cancer 2010; 54: 176.
32. Mazereeuw-Hautier J, Hoeger PH, Benlahrech S, et al. Efficacy of propranolol in hepatic infantile hemangiomas with diffuse neonatal hemangiomatosis. J Pediatr 2010; 157: 340-342.